PBYI
Puma Biotechnology Stock Analysis
AI Rating
- Quality9/10
- Growth↑ 6/10
- Value↓ 4/10
PBYI Growth
- Revenue Y/Y↓ -4.81%
- EPS Y/Y↓ -35.06%
- FCF Y/Y↑ 71.96%
PBYI Profitability
- Gross margin ↑ 74.50%
- EPS margin↑ 10.70%
- ROIC 5Y↑ 42.52%
PBYI Risk
- Debt / Equity↓ 0.1
- Debt / FCF↓ 0.0
- Interest coverage↑ 6.6
Puma Biotechnology stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.